The use of diuretics in heart failure with congestion—a position statement from the Heart Failure Association of the European Society of Cardiology

…, A Mebazaa, HP BrunnerLa Rocca… - European journal of …, 2019 - Wiley Online Library
The vast majority of acute heart failure episodes are characterized by increasing symptoms
and signs of congestion with volume overload. The goal of therapy in those patients is the …

Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure …

…, J Bauersachs, HP BrunnerLa Rocca… - European journal of …, 2017 - Wiley Online Library
Organ injury and impairment are commonly observed in patients with acute heart failure (AHF),
and congestion is an essential pathophysiological mechanism of impaired organ function…

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis

…, CM Frampton, HP Brunner-La Rocca… - European heart …, 2014 - academic.oup.com
Aims Natriuretic peptide-guided (NP-guided) treatment of heart failure has been tested against
standard clinically guided care in multiple studies, but findings have been limited by study …

[HTML][HTML] Empagliflozin in heart failure with a preserved ejection fraction

…, M Böhm, HP BrunnerLa Rocca… - … England Journal of …, 2021 - Mass Medical Soc
Background Sodium–glucose cotransporter 2 inhibitors reduce the risk of hospitalization for
heart failure in patients with heart failure and a reduced ejection fraction, but their effects in …

[HTML][HTML] Cardiovascular and renal outcomes with empagliflozin in heart failure

…, S Kaul, HP Brunner-La Rocca… - … England Journal of …, 2020 - Mass Medical Soc
Background Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization
for heart failure in patients regardless of the presence or absence of diabetes. More …

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents

M Pfisterer, HP Brunner-La Rocca, PT Buser… - Journal of the american …, 2006 - jacc.org
Objectives : We sought to define the incidence of late clinical events and late stent thrombosis
in patients treated with drug-eluting (DES) versus bare-metal stents (BMS) after the …

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

…, O Paz, S Viskin, D Zwas, HP Brunner-La Rocca… - The Lancet, 2020 - thelancet.com
Background Cardiac muscle hypercontractility is a key pathophysiological abnormality in
hypertrophic cardiomyopathy, and a major determinant of dynamic left ventricular outflow tract (…

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME …

…, P Hilti, R Schindler, HP Brunner-La Rocca… - Jama, 2009 - jamanetwork.com
… Author Contributions: Drs Pfisterer and Brunner-La Rocca had full access to all of the data
in the study and take responsibility for the integrity of the data and the accuracy of the data …

Effect of school based physical activity programme (KISS) on fitness and adiposity in primary schoolchildren: cluster randomised controlled trial

…, T Hartmann, H Hebestreit, HP Brunner-La Rocca… - Bmj, 2010 - bmj.com
Brunner-La Rocca, professor of cardiology,5 Willem van Mechelen, professor of occupational
and sports medicine,6 Jardena J Puder, assistant professor of endocrinology, diabetes …

Neural mechanisms in human obesity-related hypertension

…, GH Wiesner, HP Brunner-La Rocca… - Journal of …, 1999 - journals.lww.com
Objective Two hypotheses concerning mechanisms of weight gain and of blood pressure
elevation in obesity were tested. The first hypothesis is that in human obesity sympathetic …